ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,409,969 | +222.9% | 605,137 | +519.6% | 0.00% | – |
| Q1 2024 | $436,599 | -61.9% | 97,673 | -72.6% | 0.00% | – |
| Q4 2023 | $1,145,742 | +1256.1% | 356,929 | +1239.2% | 0.00% | – |
| Q3 2023 | $84,490 | -84.9% | 26,653 | -76.4% | 0.00% | – |
| Q2 2023 | $561,128 | +88.1% | 112,903 | +86.9% | 0.00% | – |
| Q1 2023 | $298,381 | +370.0% | 60,401 | +498.4% | 0.00% | – |
| Q4 2022 | $63,491 | -96.4% | 10,094 | -93.9% | 0.00% | -100.0% |
| Q3 2022 | $1,782,000 | +85.4% | 165,007 | +95.7% | 0.00% | – |
| Q2 2022 | $961,000 | +76.0% | 84,301 | +40.8% | 0.00% | – |
| Q1 2022 | $546,000 | -72.8% | 59,865 | -55.4% | 0.00% | – |
| Q4 2021 | $2,004,000 | +133.6% | 134,313 | +302.7% | 0.00% | – |
| Q3 2021 | $858,000 | +86.9% | 33,354 | +89.5% | 0.00% | – |
| Q2 2021 | $459,000 | +9.3% | 17,600 | +48.0% | 0.00% | – |
| Q1 2021 | $420,000 | -44.2% | 11,895 | -60.2% | 0.00% | – |
| Q4 2020 | $753,000 | -33.4% | 29,858 | -0.4% | 0.00% | -100.0% |
| Q3 2020 | $1,130,000 | -16.0% | 29,977 | -4.5% | 0.00% | 0.0% |
| Q2 2020 | $1,345,000 | +80.8% | 31,405 | +15.1% | 0.00% | 0.0% |
| Q3 2019 | $744,000 | – | 27,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |